Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0026 Transporter Info
Gene Name SLC22A11
Transporter Name Organic anion transporter 4
Gene ID
55867
UniProt ID
Q9NSA0
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Probenecid

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Probenecid inhibits the transportation of Ochratoxin A by SLC22A11 (Ki = 44.4 microM) [1]

Affected Drug/Substrate

 Ochratoxin A Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  DT Modulation 2

 Probenecid inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 54.9 microM) [2]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  DT Modulation 3

 Probenecid inhibits the transportation of Estrone sulfate by SLC22A11 [5]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Candesartan

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Candesartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 60 microM) [3]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  DT Modulation 2

 Candesartan inhibits the activity of SLC22A11 (Ki = 88.9 microM) [4]

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  DT Modulation 3

 Candesartan inhibits the activity of SLC22A11 [4]

  Piroxicam

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Piroxicam inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 84.9 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  DT Modulation 2

 Piroxicam inhibits the transportation of Ochratoxin A by SLC22A11 (Ki = 107.8 microM) [1]

Affected Drug/Substrate

 Ochratoxin A Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Losartan

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Losartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 18 microM) [3]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  DT Modulation 2

 Losartan inhibits the activity of SLC22A11 (Ki = 24.8 microM) [4]

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Valsartan

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valsartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 26 microM) [3]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  DT Modulation 2

 Valsartan inhibits the activity of SLC22A11 (Ki = 19.6 microM) [4]

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Acetazolamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetazolamide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 425 microM) [7]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Bumetanide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bumetanide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 348 microM) [7]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Chlorothiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlorothiazide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 2632 microM) [7]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Ethacrynic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethacrynic acid inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 8.76 microM) [7]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Furosemide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Furosemide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 44.5 microM) [7]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Trichlormethiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Trichloromethiazide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 1505 microM) [7]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Novobiocin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Novobiocin inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 92.68 microM; Ki = 90.5 microM) [8]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)7-OAT4

  Diclofenac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diclofenac inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 34.5 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Ibuprofen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ibuprofen inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 103 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Indomethacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indomethacin inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 10.1 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Ketoprofen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoprofen inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 70.3 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Mefenamic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mefenamic acid inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 61.7 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Naproxen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Naproxen inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 85.4 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Sulindac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulindac inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 617 microM) [6]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Betamipron

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Betamipron inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 502 microM) [2]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Cefamandole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefamandole inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 1140 microM) [10]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Cefazolin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefazolin inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 1740 microM) [10]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Cefoperazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefoperazone inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 2800 microM) [10]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Cefotaxime

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefotaxime inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 6150 microM) [10]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Ceftriaxone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ceftriaxone inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 2380 microM) [10]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Cephalothin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephalothin inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 200 microM) [10]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Olmesartan medoxomil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Olmesartan medoxomil inhibits the transportation of Uric acid by SLC22A11 (IC50 = 4.4 microM) [3]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Telmisartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Telmisartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 1.2 microM) [3]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Candesartan cilexetil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Candesartan cilexetil inhibits the activity of SLC22A11 (Ki = 135.2 microM) [4]

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Zidovudine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zidovudine inhibits the transportation of Estrone sulfate by SLC22A11 [11]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Linagliptin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Linagliptin inhibits the transportation of Estrone sulfate by SLC22A11 [5]

Affected Drug/Substrate

 Estrone sulfate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Phenylbutazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenylbutazone inhibits the transportation of Methotrexate by SLC22A11 [12]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen inhibits the activity of SLC22A11 [6]

  Aspirin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aspirin inhibits the activity of SLC22A11 [6]

  Troglitazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Troglitazone increases the expression of SLC22A11 [14]

  Calcitriol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Calcitriol inhibits the expression of SLC22A11 [15]

  Decitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Decitabine increases the expression of SLC22A11 [16]

  Pranlukast

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pranlukast inhibits the activity of SLC22A11 [4]

  Lesinurad

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lesinurad inhibits the activity of SLC22A11 [17]

  Cabazitaxel

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cabazitaxel inhibits the activity of SLC22A11 [18]

Drug in Phase 2/3 Trial

  Salicylic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Salicylic Acid inhibits the activity of SLC22A11 [6]

Drug in Phase 3 Trial

  KW-3902

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 KW-3902 inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 20.7 microM) [2]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Pratosartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pratosartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 31 microM) [3]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

  Benzylpenicillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzylpenicillin inhibits the transportation of Methotrexate by SLC22A11 [12]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

Drug in Phase 2 Trial

  Bisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bisphenol A inhibits the expression of SLC22A11 [22]

Drug in Phase 1/2 Trial

  PRI-724

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 PRI-724 markedly inhibits the activity of SLC22A11 [19]

Cell System

 Human embryonic kidney 293 cells (HEK293)-

Investigative Drug

  Beta-naphthoflavone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Beta-naphthoflavone inhibits the expression of SLC22A11 [24]

  21H7

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 21H7 inhibits the activity of SLC22A11 [19]

Cell System

 Human embryonic kidney 293 cells (HEK293)-

  FH535

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 FH535 inhibits the activity of SLC22A11 [19]

Cell System

 Human embryonic kidney 293 cells (HEK293)-

Drug Withdrawn

  Cephaloridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephaloridine inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 3630 microM) [10]

Affected Drug/Substrate

 Prostaglandin F2alpha Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Phenacetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenacetin inhibits the activity of SLC22A11 [6]

Natural Product

  Cigarette smoke condensate (0.32mg/ml)

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cigarette smoke condensate (0.32mg/ml) inhibits the activity of SLC22A11 [13]

Cell System

 Human embryonic kidney 293 cells (HEK293)-OAT4

Environmental toxicant

  Tetrabromobisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetrabromobisphenol A increases the expression of SLC22A11 [22]

Mycotoxins

  Aflatoxin B1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aflatoxin B1 inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Alpha-zearalenol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Alpha-zearalenol inhibits the transportation of Organic anion by SLC22A11 (IC50 = 130 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Citrioveridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Citrioveridine inhibits the transportation of Organic anion by SLC22A11 (IC50 = 823 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Cyclopiazonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A11 (IC50 = 86.6 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Fumonisin B1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fumonisin B1 inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Patulin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Patulin inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Gliotoxin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gliotoxin inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

  Zearalenone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zearalenone inhibits the transportation of Organic anion by SLC22A11 (IC50 = 103 microM) [9]

Affected Drug/Substrate

 Organic anion Modulation Type Inhibition

Cell System

 The Proximal Tubule (S2) Cells-OAT4

Carcinogen

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene increases the expression of SLC22A11 [23]

Health and Environmental Toxicant

  Lead

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lead increases the expression of SLC22A11 [20]

  Butyraldehyde

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Butyraldehyde inhibits the expression of SLC22A11 [21]
References
1 Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim Biophys Acta. 2002 Jun 12;1590(1-3):64-75.
2 Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther. 2002 Jun;301(3):797-802.
3 Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46.
4 Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4. J Pharm Pharmacol. 2006 Nov;58(11):1499-505.
5 Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods. Drug Metab Dispos. 2013 Jan;41(1):149-58.
6 Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 2002 Nov;303(2):534-9.
7 Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9.
8 Novobiocin is a potent inhibitor for human organic anion transporters. Drug Metab Dispos. 2009 Jun;37(6):1203-10.
9 Interactions of organic anion transporters and organic cation transporters with mycotoxins. J Pharmacol Sci. 2008 Mar;106(3):435-43.
10 Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol. 2003 Mar 28;465(1-2):1-7.
11 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
12 Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.
13 Inhibition of organic anion transporter (OAT) activity by cigarette smoke condensate. Toxicol In Vitro. 2017 Oct;44:27-35.
14 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
15 Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J Steroid Biochem Mol Biol. 2016 Oct;163:77-87.
16 Multiple drug transporters mediate the placental transport of sulpiride. Arch Toxicol. 2017 Dec;91(12):3873-3884.
17 Lesinurad: A Review in Hyperuricaemia of Gout. Drugs Aging. 2017 May;34(5):401-410.
18 Inhibitory effects of chemotherapeutics on human organic anion transporter hOAT4. Int J Biochem Mol Biol. 2016 Jun 1;7(1):11-8. eCollection 2016.
19 Impaired Transport Activity of Human Organic Anion Transporters (OATs) and Organic Anion Transporting Polypeptides (OATPs) by Wnt Inhibitors. J Pharm Sci. 2021 Feb;110(2):914-924.
20 Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res. 2011 Jan;19(1):1-13.
21 Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity. Toxicology. 2015 Aug 6;334:111-21.
22 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49.
23 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297.
24 Aryl hydrocarbon receptor (AhR) agonist beta-naphthoflavone regulated gene networks in human primary trophoblasts. Reprod Toxicol. 2020 Sep;96:370-379.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.